The global intraoperative imaging market size is expected to reach USD 5.41 billion by 2030, expanding at a CAGR of 6.70% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rise in the number of chronic disorders worldwide and the growing number of geriatric populations are driving the market. Additionally, the increase in the adoption of minimally invasive surgeries coupled with technological advancements are factors influencing the market growth.
Intraoperative imaging is a highly efficient device that provides real-time images during surgery, helping surgeons to discover abnormal tissues and operate more precisely. Furthermore, the use of intraoperative devices has aided healthcare facilities in reducing the expense of repeat surgeries, thus lowering the overall financial load on patients. The majority of surgeries are now performed using minimally invasive techniques to protect muscle and healthy tissues, different types of intraoperative imaging systems are often employed to evaluate surgical precision to do this as effectively as possible.
The rising prevalence of chronic diseases like cancer, stroke, neurological conditions, orthopedics, and cardiovascular diseases, which require surgical interventions, is expected to expand the market during the forecast period. As per the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The same source stated that between 30 and 50% of cancers can be prevented by avoiding risk factors and implementing evidence-based prevention strategies.
The market's prominent competitors are taking different initiatives, such as the acquisition and funding of medium and small-sized businesses, to expand their product portfolio and enhance their manufacturing capacity. For instance, In July 2020, C-arm developer Ziehm acquired Therenva, a French-based developer of planning and imaging software solutions for cardiovascular procedures.
Intraoperative Imaging Market Report Highlights
By product, the C-arm segment dominated the market in 2023, owing to its flexibility to move around the patient, allowing it to achieve the best angle for a high-quality image while keeping the patient comfortable
The neurosurgery application segment, dominated the market in 2023, owing to the increasing prevalence of neurological disorders
The oncology application segment is expected to expand significantly during the forecast period, due to the rapid increase in cancer cases globally
In terms of end-use, the hospital segment held the largest share in 2023, owing to the increase in the adoption of technologically advanced intraoperative imaging systems in hospitals for better patient outcomes
North America dominated the market and accounted for the largest revenue share in 2023
Asia Pacific is anticipated to be growing at the fastest CAGR during the forecast period due to the presence of untapped opportunities in the emerging economies of China and India
Please note The report will be delivered in 4-6 business days upon order notification.
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America